Compass Pathways ROCE 2024

Compass Pathways Aktienanalyse

What does Compass Pathways do?

Compass Pathways PLC is a leading company specializing in the development of groundbreaking therapies for the treatment of mental illnesses. The company was founded in 2016 and is headquartered in London. Its goal is to revolutionize the treatment of depression and other mental illnesses. The business model of Compass Pathways is based on researching psychedelics as a potential treatment for patients suffering from severe depression and anxiety disorders. The company uses innovative approaches to precisely study the effects of psychedelics on the human brain and develop new therapy concepts and products from that. An important area of Compass Pathways is clinical research. The company collaborates closely with leading research institutions to understand the impacts of psychedelics on the human brain. The research results are then used to develop innovative methods for therapeutic use of psychedelics. Another important area of Compass Pathways is the development of therapeutic products. The company has developed a patented process for producing psilocybin, a substance found in hallucinogenic mushrooms. This process achieves a very high purity of the substance, enabling precise dosing and better control of its effects. The flagship product of Compass Pathways is COMP360, a medication based on psilocybin that is being developed for the treatment of depression. The medication is currently in clinical Phase 2 trials, showing promising results. If COMP360 receives approval, it has the potential to drastically change the way we treat depression. Compass Pathways is also active in other areas. The company conducts a range of research projects related to various psychedelic substances, including LSD and other hallucinogens. Another important area of Compass Pathways is training therapists and other professionals in the use of psychedelic substances. The company offers relevant courses to promote understanding of the therapeutic use of psychedelics and enable their safe and effective application for patient treatment. Overall, Compass Pathways is a company focused on the development of groundbreaking therapies for mental illnesses. Through combining cutting-edge research, innovative products, and professional education, the company has the potential to revolutionize the way we treat mental illnesses. Compass Pathways ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROCE Details

Unraveling Compass Pathways's Return on Capital Employed (ROCE)

Compass Pathways's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Compass Pathways's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Compass Pathways's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Compass Pathways’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Compass Pathways Stock

What is the ROCE (Return on Capital Employed) of Compass Pathways this year?

The ROCE of Compass Pathways is -0.56 undefined this year.

How has the ROCE (Return on Capital Employed) of Compass Pathways developed compared to the previous year?

The ROCE of Compass Pathways has increased by 3.12% increased compared to the previous year.

What does a high ROCE (Return on Capital Employed) mean for investors of Compass Pathways?

A high Return on Capital Employed (ROCE) indicates that Compass Pathways has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.

What does a low ROCE (Return on Capital Employed) mean for investors of Compass Pathways?

A low ROCE (Return on Capital Employed) can indicate that Compass Pathways has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.

How does an increase in ROCE from Compass Pathways impact the company?

An increase in the ROCE of Compass Pathways can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.

How does a reduction in the ROCE of Compass Pathways affect the company?

A decrease in ROCE of Compass Pathways can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.

What are some factors that can influence the ROCE of Compass Pathways?

Some factors that can affect Compass Pathways's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.

Why is the ROCE of Compass Pathways so important for investors?

The ROCE of Compass Pathways is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.

What strategic measures can Compass Pathways take to improve the ROCE?

To improve the ROCE, Compass Pathways can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.

How much dividend does Compass Pathways pay?

Over the past 12 months, Compass Pathways paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Compass Pathways is expected to pay a dividend of 0 USD.

What is the dividend yield of Compass Pathways?

The current dividend yield of Compass Pathways is .

When does Compass Pathways pay dividends?

Compass Pathways pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Compass Pathways?

Compass Pathways paid dividends every year for the past 0 years.

What is the dividend of Compass Pathways?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Compass Pathways located?

Compass Pathways is assigned to the 'Health' sector.

Wann musste ich die Aktien von Compass Pathways kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Compass Pathways from 6/6/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/6/2024.

When did Compass Pathways pay the last dividend?

The last dividend was paid out on 6/6/2024.

What was the dividend of Compass Pathways in the year 2023?

In the year 2023, Compass Pathways distributed 0 USD as dividends.

In which currency does Compass Pathways pay out the dividend?

The dividends of Compass Pathways are distributed in USD.